Bank Of New York Mellon Corp F Star Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.09 - $6.86 $217,268 - $364,416	53,122 New	53,122 $335,000
Q2 2022 Aug 15, 2022	BUY	$2.18 - $6.39 $16,740 - $49,068	7,679 Added 16.78%	53,431 $334,000
Q3 2021 Nov 12, 2021	BUY	$5.2 - $8.42 $3,588 - $5,809	690 Added 1.53%	45,752 $335,000
Q2 2021 Aug 11, 2021	BUY	$6.57 - $10.71 $296,057 - $482,614	45,062 New	45,062 $387,000

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.